stockrowWarby Parker Inc.
WRBY Healthcare Medical Instruments & Supplies
Warby Parker Inc.’s revenue for fiscal 2025 (year ended December 2025) was $871.9 million, up 13.0% from fiscal 2024.
- Revenue
- +10.4%
- EPS
- −20.0%
- Free cash flow
- −30.3%
Quarter to September 2026, against a year earlier
Follow WRBY
Alert me
Warby Parker Inc. (WRBY) Current ratio
Warby Parker Inc.'s current ratio at the end of the quarter to 30 September 2026 was 2.3×, down 0.1× from fiscal 2025 (2.3×). Over the past ten years it has ranged from 1.2× (fiscal 2019) to 3.4× (fiscal 2020); the current reading is higher than 43% of that period. That is below the Medical Instruments & Supplies industry median of 2.5× and below the Healthcare sector median of 3.1×.
Current ratio, annual
Embed this chart
Annual newest first
| Period | Current ratio | Change |
|---|---|---|
| FY2025 | 2.3× | (6.14%) |
| FY2024 | 2.5× | 6.45% |
| FY2023 | 2.3× | 3.34% |
| FY2022 | 2.3× | (18.12%) |
| FY2021 | 2.8× | (18.73%) |
| FY2020 | 3.4× | 182.76% |
| FY2019 | 1.2× | — |
Quarterly newest first
| Period | Current ratio | Change |
|---|---|---|
| Sep 2026 | 2.3× | (0.51%) |
| Jun 2026 | 2.3× | (2.79%) |
| Mar 2026 | 2.3× | (0.60%) |
| Dec 2025 | 2.3× | (9.89%) |
| 19 more quarters | Free account |
Against its own ten years
Current ratio against peers
| Company | Current ratio |
|---|---|
| LMAT LeMaitre Vascular, Inc. compare | 14.6× |
| PLSE Pulse Biosciences, Inc compare | 14.3× |
| KMTS Kestra Medical Technologies, Ltd. compare | 4.7× |
| ATRC AtriCure, Inc. compare | 4.3× |
| AZTA Azenta, Inc. compare | 2.5× |
| ICUI ICU Medical, Inc. compare | 2.4× |
| WRBY Warby Parker Inc. | 2.3× |
| STVN Stevanato Group S.p.A. compare | 1.7× |
| XRAY DENTSPLY SIRONA Inc. compare | 1.6× |
| Medical Instruments & Supplies industry median | 2.5× |
| Healthcare sector median | 3.1× |
| Market median | 1.6× |
What Current ratio is
Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.
Current Assets (Total) ÷ Current Liabilities (Total)
More on WRBY
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement